Southwest to Pour $...
Health Care: Health Services
Response Genetics Inc. (RGDX: NASDAQ)
$1.68 0.08 | 5.00%
05/24/12 - 03:59 PM ET
219.57K / 35.50K
Vol / Avg. Vol:1.55 / 1.60
Open / Prev. Close:1.51 - 2.05
Today's Range:0.81 - 3.05
52 Wk Range:9.80%
Performance YTD:TheStreet Rating:
Portfolios with RGDX
- Portfolio NameUser Type
- Userjaysan Portfolio 1
- Usercurry Portfolio 1
- Usercharlesl950 Portfolio 1
- UserWACKJDDUDE Portfolio 1
Latest RGDX Headlines from TheStreet
- Maguire Properties, Compugen: Midday Volume Plays 05.11.10 | 11:05 am
- Director Sells $7.4M Worth of Copart 07.01.09 | 10:07 am
Press Releases for RGDX
- Response Genetics, Inc. Announces First Quarter Financial Results - Business Wire 05.10.12 | 08:05 am
- Response Genetics, Inc. To Release First Quarter Financial Results And Host Conference Call On May 10, 2012 - Business Wire 05.04.12 | 08:05 am
- Response Genetics, Inc. Announces Year-End And Fourth Quarter Financial Results - Business Wire 03.27.12 | 08:03 am
- Response Genetics, Inc. Announces Appointment Of Stephanie Astrow, Ph.D., As Vice President, Research And Development - Business Wire 03.26.12 | 08:03 am
- Response Genetics, Inc. To Release Fourth Quarter And Full-Year 2011 Financial Results And Host Conference Call On March 27, 2012 - Business Wire 03.21.12 | 08:03 am
- Response Genetics Regains NASDAQ Compliance - Business Wire 02.21.12 | 07:02 am
- Response Genetics To Present At The 22nd Annual UBS Global Healthcare Services Conference - Business Wire 02.06.12 | 07:02 am
- Response Genetics Raises More Than $7.8 Million In Financing - Business Wire 02.02.12 | 07:02 am
- Response Genetics Names Thomas A. Bologna Chairman And CEO - Business Wire 12.22.11 | 08:12 am
- Response Genetics, Inc. To Offer FDA-Approved ALK Test For Metastatic NSCLC - Business Wire 12.21.11 | 11:12 am
Partner Headlines for RGDX
- Response Genetics: This Train Is About To Leave The Station - Seeking Alpha 02.16.12 | 09:02 am
- Response Genetics Stock Soars 31% On $7.8M Offering News - Seeking Alpha 02.03.12 | 08:02 am
- Biomarker Diagnostics Drive Personalized Medicine but Path to Market Still Rife With Hurdles - Seeking Alpha 07.07.10 | 07:07 am
- Three Promising Small-Cap Cancer Plays - Seeking Alpha 05.17.10 | 08:05 am
- Response Genetics: An Earnings Primer - Seeking Alpha 05.12.10 | 06:05 am
- UPDATE 1-Response Genetics inks deal with Glaxo, shares soar - Reuters 05.11.10 | 10:05 am
